Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study.

Shinozaki, Satoshi; Tahara, Toshiyuki; Miura, Kouichi; Lefor, Alan Kawarai; Yamamoto, Hironori

Shinozaki, Satoshi; Tahara, Toshiyuki; Miura, Kouichi; Lefor, Alan Kawarai; Yamamoto, Hironori.

Afiliación

Shinozaki S; Shinozaki Medical Clinic, Utsunomiya 321-3223, Japan.
Tahara T; Department of Medicine, Division of Gastroenterology, Jichi Medical University, Tochigi 329-0431, Japan.
Miura K; Saiseikai Utsunomiya Hospital, 911-1 Takebayashi, Utsunomiya 321-0974, Japan.
Lefor AK; Department of Medicine, Division of Gastroenterology, Jichi Medical University, Tochigi 329-0431, Japan.
Yamamoto H; Department of Surgery, Jichi Medical University, Tochigi 329-0431, Japan.

Life (Basel) ; 13(6)2023 Jun 05.

Article en En | MEDLINE | ID: mdl-37374110

Palabras clave

PPAR-alpha; dyslipidemias; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; pemafibrate; sodium glucose transporter-2 inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Life (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google